Eli Lilly Pulls Ahead Of Novo In Obesity Drug Gold Rush As New Players Crowd In
Image Source: Unsplash The global weight-loss drug market, once dominated by Novo Nordisk (NVO), is undergoing a dramatic transformation. On Friday, the Danish pharmaceutical giant announced it would replace its long-serving chief executive, Lars …